The Maryland Stem Cell Research Commission has awarded $1.35 million through five grants as part of the commission’s first round of funding for the fiscal year, the commission announced Tuesday.
The Maryland Stem Cell Research Commission is charged with fostering research and innovation in regenerative medicine.
It disburses grants from the Maryland Stem Cell Research Fund to promote state-funded stem cell research and provides grants to public and private entities for their research. These grants are for both the validation of research ideas and to help commercialize ideas in startups.
Stem cells are a small but significant part of the state’s biotech economy. One of the state’s more prominent stem cell companies, Frederick’s Rooster Bio, has raised at least $15 million of a planned $22 million Series B round, the company announced last month.
In the grants announced Tuesday, three startups were awarded a total of $892,080. Those companies were Propagenix, NeoProgen and Reprocell.
Two Johns Hopkins University researchers were awarded validation grants totaling $459,320: Amer Riazuddin and Peter Andersen.
“We are enthusiastic about the volume and the high level of the applications and are looking forward to working with these awardees,” Dan Gincel, the commission’s executive director, said in a statement. “These university validation projects and company commercialization awards have some of the most advanced science and technology we have yet to see.”
The commission also announced new leadership, electing Debra Mathews and Curt Van Tassell as its chair and vice chair.